A Yersinia pestis YscN ATPase mutant functions as a live attenuated vaccine against bubonic plague in mice

FEMS Microbiology Letters

Volumn 332, Issue 2, 2012, Pages 113-121

  Bozue, Joel ^a   Cote, Christopher K ^a   Webster, Wendy ^a   Bassett, Anthony ^a   Tobery, Steven ^a   Little, Stephen ^a   Swietnicki, Wieslaw ^a,b  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b Life Science Division   (Poland)

Author keywords

Live vaccine; Plague; Yersinia pestis; YscN

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BACTERIAL PROTEIN; BACTERIAL VACCINE; CALCIUM; LCRV PROTEIN; LIVE VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM MUTANT; BUBONIC PLAGUE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE EXPRESSION PROFILING; INFECTION PREVENTION; LETTER; MOUSE; NONHUMAN; PLAGUE; PRIORITY JOURNAL; PROVOCATION TEST; VIRULENCE; YERSINIA PESTIS; YSCN GENE;

ADENOSINE TRIPHOSPHATASES; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; CARRIER PROTEINS; DNA, BACTERIAL; FEMALE; GENETIC COMPLEMENTATION TEST; MICE; PLAGUE; PLAGUE VACCINE; SEQUENCE DELETION; VACCINES, ATTENUATED; VIRULENCE FACTORS; YERSINIA PESTIS;

BACTERIA (MICROORGANISMS); MUS; YERSINIA PESTIS;

EID: 84862600010     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2012.02583.x     Document Type: Letter

References (61)

1. Agin TS, Zhu C, Johnson LA, Thate TE, Yang Z & Boedeker EC (2005) Protection against hemorrhagic colitis in an animal model by oral immunization with isogeneic rabbit enteropathogenic Escherichia coli attenuated by truncating intimin. Infect Immun 73: 6608-6619.
2. Akeda Y & Galan JE (2005) Chaperone release and unfolding of substrates in type III secretion. Nature 437: 911-915.
3. Anderson GW Jr, Leary SE, Williamson ED, Titball RW, Welkos SL, Worsham PL & Friedlander AM (1996) Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis. Infect Immun 64: 4580-4585.
4. Anisimov AP, Panfertsev EA, Svetoch TyE & Dentovskaya SV (2007) Variability of the protein sequences of LcrV between epidemic and atypical rhamnose-positive strains of Yersinia pestis. The Genus Yersinia: From Genomics to Function Vol. 603 (Perry RD & Fetherston JD, eds), pp. 23-27. Springer, New York.
5. Benner GE, Andrews GP, Byrne WR, Strachan SD, Sample AK, Heath DG & Friedlander AM (1999) Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice. Infect Immun 67: 1922-1928.
6. Blaylock B, Riordan KE, Missiakas DM & Schneewind O (2006) Characterization of the Yersinia enterocolitica type III secretion ATPase YscN and its regulator, YscL. J Bacteriol 188: 3525-3534.
7. Bozue J, Mou S, Moody KL, Cote CK, Trevino S, Fritz D & Worsham P (2011) The role of the phoPQ operon in the pathogenesis of the fully virulent CO92 strain of Yersinia pestis and the IP32953 strain of Yersinia pseudotuberculosis. Microb Pathog 50: 314-321.
8. Byvalov AA, Pautov VN, Chicherin IuV, Lebedinskii VA & Evtigneev VI (1984) [Effectiveness of revaccinating hamadryas baboons with NISS live dried plague vaccine and fraction I of the plague microbe]. Zh Mikrobiol Epidemiol Immunobiol: 74-76.
9. Cathelyn JS, Crosby SD, Lathem WW, Goldman WE & Miller VL (2006) RovA, a global regulator of Yersinia pestis, specifically required for bubonic plague. P Natl Acad Sci USA 103: 13514-13519.
10. Chen TH & Elberg SS (1977) Scanning electron microscopic study of virulent Yersinia pestis and Yersinia pseudotuberculosis type 1. Infect Immun 15: 972-977.
11. Conchas RF & Carniel E (1990) A highly efficient electroporation system for transformation of Yersinia. Gene 87: 133-137.
12. Cornelis GR (2002a) The Yersinia Ysc-Yop virulence apparatus. Int J Med Microbiol 291: 455-462.
13. Cornelis GR (2002b) Yersinia type III secretion: send in the effectors. J Cell Biol 158: 401-408.
14. Cornelis GR, Biot T, Lambert De Rouvroit Cet al. (1989) The Yersinia yop regulon. Mol Microbiol 3: 1455-1459.
15. Davis KJ, Fritz DL, Pitt ML, Welkos SL, Worsham PL & Friedlander AM (1996) Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops). Arch Pathol Lab Med 120: 156-163.
16. DiMezzo TL, Ruthel G, Brueggemann EEet al. (2009) In vitro intracellular trafficking of virulence antigen during infection by Yersinia pestis. PLoS ONE 4: e6281.
17. Doll JM, Zeitz PS, Ettestad P, Bucholtz AL, Davis T & Gage K (1994) Cat-transmitted fatal pneumonic plague in a person who traveled from Colorado to Arizona. Am J Trop Med Hyg 51: 109-114.
18. Feunou PF, Ismaili J, Debrie ASet al. (2008) Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1. Vaccine 26: 5722-5727.
19. Friedlander AM, Welkos SL, Worsham PLet al. (1995) Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Clin Infect Dis 21(Suppl 2): S178-S181.
20. Galan JE (2008) Energizing type III secretion machines: what is the fuel? Nat Struct Mol Biol 15: 127-128.
21. Galyov EE, Smirnov O, Karlishev AVet al. (1990) Nucleotide sequence of the Yersinia pestis gene encoding F1 antigen and the primary structure of the protein. Putative T and B cell epitopes. FEBS Lett 277: 230-232.
22. Heath DG, Anderson GW Jr, Mauro JM, Welkos SL, Andrews GP, Adamovicz J & Friedlander AM (1998) Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine 16: 1131-1137.
23. Higuchi K, Kupferberg LL & Smith JL (1959) Studies on the nutrition and physiology of Pasteurella pestis. III. Effects of calcium ions on the growth of virulent and avirulent strains of Pasteurella pestis. J Bacteriol 77: 317-321.
24. Isherwood KE, Titball RW, Davies DH, Felgner PL & Morrow WJ (2005) Vaccination strategies for Francisella tularensis. Adv Drug Deliv Rev 57: 1403-1414.
25. Kummer LW, Szaba FM, Parent MA, Adamovicz JJ, Hill J, Johnson LL & Smiley ST (2008) Antibodies and cytokines independently protect against pneumonic plague. Vaccine 26: 6901-6907.
26. Little SF, Webster WM, Wilhelm H, Powell B, Enama J & Adamovicz JJ (2008) Evaluation of quantitative anti-F1 IgG and anti-V IgG ELISAs for use as an in vitro-based potency assay of plague vaccine in mice. Biologicals 36: 287-295.
27. Liu F, Chen H, Galvan EM, Lasaro MA & Schifferli DM (2006) Effects of Psa and F1 on the adhesive and invasive interactions of Yersinia pestis with human respiratory tract epithelial cells. Infect Immun 74: 5636-5644.
28. Mann P, Goebel E, Barbarich J, Pilione M, Kennett M & Harvill E (2007) Use of a genetically defined double mutant strain of Bordetella bronchiseptica lacking adenylate cyclase and type III secretion as a live vaccine. Infect Immun 75: 3665-3672.
29. Meyer KF, Hightower JA & Mccrumb FR (1974a) Plague immunization. VI. Vaccination with the fraction I antigen of Yersinia pestis. J Infect Dis 129(Suppl): S41-S45.
30. Meyer KF, Smith G, Foster L, Brookman M & Sung M (1974b) Live, attenuated Yersinia pestis vaccine: virulent in nonhuman primates, harmless to guinea pigs. J Infect Dis 129(Suppl): S85-120.
31. Motin VL, Nakajima R, Smirnov GB & Brubaker RR (1994) Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide. Infect Immun 62: 4192-4201.
32. Nilles ML, Fields KA & Straley SC (1998) The V antigen of Yersinia pestis regulates Yop vectorial targeting as well as Yop secretion through effects on YopB and LcrG. J Bacteriol 180: 3410-3420.
33. Okan NA, Mena P, Benach JL, Bliska JB & Karzai AW (2010) The smpB-ssrA mutant of Yersinia pestis functions as a live attenuated vaccine to protect mice against pulmonary plague infection. Infect Immun 78: 1284-1293.
34. Oyston PC, Mellado-Sanchez G, Pasetti MF, Nataro JP, Titball RW & Atkins HS (2010) A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infection. Microb Pathog 48: 191-195.
35. Pasquali P, Ammendola S, Pistoia Cet al. (2008) Attenuated Salmonella enterica serovar Typhimurium lacking the ZnuABC transporter confers immune-based protection against challenge infections in mice. Vaccine 26: 3421-3426.
36. Paul K, Erhardt M, Hirano T, Blair DF & Hughes KT (2008) Energy source of flagellar type III secretion. Nature 451: 489-492.
37. Payne PL & Straley SC (1998) YscO of Yersinia pestis is a mobile core component of the Yop secretion system. J Bacteriol 180: 3882-3890.
38. Payne PL & Straley SC (1999) YscP of Yersinia pestis is a secreted component of the Yop secretion system. J Bacteriol 181: 2852-2862.
39. Perry RD & Fetherston JD (1997) Yersinia pestis-etiologic agent of plague. Clin Microbiol Rev 10: 35-66.
40. Pettersson J, Holmstrom A, Hill Jet al. (1999) The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation. Mol Microbiol 32: 961-976.
41. Powell BS, Andrews GP, Enama JTet al. (2005) Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague. Biotechnol Prog 21: 1490-1510.
42. Quenee LE, Cornelius CA, Ciletti NA, Elli D & Schneewind O (2008) Yersinia pestis caf1 variants and the limits of plague vaccine protection. Infect Immun 76: 2025-2036.
43. Ritchie JM & Waldor MK (2005) The locus of enterocyte effacement-encoded effector proteins all promote enterohemorrhagic Escherichia coli pathogenicity in infant rabbits. Infect Immun 73: 1466-1474.
44. Roggenkamp A, Geiger AM, Leitritz L, Kessler A & Heesemann J (1997) Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen. Infect Immun 65: 446-451.
45. Rosqvist R, Magnusson KE & Wolf-Watz H (1994) Target cell contact triggers expression and polarized transfer of Yersinia YopE cytotoxin into mammalian cells. EMBO J 13: 964-972.
46. Sarker MR, Neyt C, Stainier I & Cornelis GR (1998a) The Yersinia Yop virulon: LcrV is required for extrusion of the translocators YopB and YopD. J Bacteriol 180: 1207-1214.
47. Sarker MR, Sory MP, Boyd AP, Iriarte M & Cornelis GR (1998b) LcrG is required for efficient translocation of Yersinia Yop effector proteins into eukaryotic cells. Infect Immun 66: 2976-2979.
48. Sorg JA, Blaylock B & Schneewind O (2006) Secretion signal recognition by YscN, the Yersinia type III secretion ATPase. P Natl Acad Sci USA 103: 16490-16495.
49. Straley SC (1991) The low-Ca2+ response virulence regulon of human-pathogenic Yersiniae. Microb Pathog 10: 87-91.
50. Straley SC, Plano GV, Skrzypek E, Haddix PL & Fields KA (1993) Regulation by Ca2+ in the Yersinia low-Ca2+ response. Mol Microbiol 8: 1005-1010.
51. Swietnicki W, Carmany D, Retford M, Guelta M, Dorsey R, Bozue J, Lee MS & Olson MA (2011) Identification of small-molecule inhibitors of Yersinia pestis type III secretion system YscN ATPase. PLoS ONE 6: e19716.
52. Une T & Brubaker RR (1984) Roles of V antigen in promoting virulence and immunity in Yersiniae. J Immunol 133: 2226-2230.
53. Viboud GI & Bliska JB (2005) Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu Rev Microbiol 59: 69-89.
54. Wang RF & Kushner SR (1991) Construction of versatile low-copy-number vectors for cloning, sequencing and gene expression in Escherichia coli. Gene 100: 195-199.
55. Welkos SL, Davis KM, Pitt LM, Worsham PL & Freidlander AM (1995) Studies on the contribution of the F1 capsule-associated plasmid pFra to the virulence of Yersinia pestis. Contrib Microbiol Immunol 13: 299-305.
56. Welkos SL, Friedlander AM & Davis KJ (1997) Studies on the role of plasminogen activator in systemic infection by virulent Yersinia pestis strain C092. Microb Pathog 23: 211-223.
57. Welkos S, Pitt ML, Martinez M, Friedlander A, Vogel P & Tammariello R (2002) Determination of the virulence of the pigmentation-deficient and pigmentation-/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague. Vaccine 20: 2206-2214.
58. Williams RC Jr, Gewurz H & Quie PG (1972) Effects of fraction I from Yersinia pestis on phagocytosis in vitro. J Infect Dis 126: 235-241.
59. Woestyn S, Allaoui A, Wattiau P & Cornelis GR (1994) YscN, the putative energizer of the Yersinia Yop secretion machinery. J Bacteriol 176: 1561-1569.
60. Worsham PL & Roy C (2003) Pestoides F, a Yersinia pestis strain lacking plasminogen activator, is virulent by the aerosol route. Adv Exp Med Biol 529: 129-131.
61. Zarivach R, Vuckovic M, Deng W, Finlay BB & Strynadka NC (2007) Structural analysis of a prototypical ATPase from the type III secretion system. Nat Struct Mol Biol 14: 131-137.